查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1597304

細胞凍結保存的全球市場的評估:各產品，各用途，各終端用戶，各地區，機會，預測(2017年～2031年)

Cell Cryopreservation Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 243 Pages | 商品交期: 3-5個工作天內

價格

全球細胞凍結保存的市場規模，被預測從2023年的95億3,000萬美元2031年達到454億9,000萬美元，預測期間的2024年～2031年年複合成長率21.58％的成長被預料。支撐市場成長，各種各樣的疾病的細胞療法的利用的擴大，對生物銀行的要求的增加，來自體外受精診所的要求的高漲，長期保存生物學的檢體的活動的擴大，導入利用先進技術的設備的主要市場企業的配合措施的高漲等。

再加上幹細胞和內臟器官，也是推進血液的提供的各國政府的配合措施，在各種各樣的民族間活性化做的事，推動細胞凍結保存市場成長。2023年，威爾斯和英格蘭的50團體和地方自治團體群組，作為專心致力為亞洲和黑人的地方自治團體的健康差距的政府的配合措施的一環，受到了約89萬美元的資金提供。以前Community Investment 作為Scheme被知道的Community Grants Program，National Health Service Blood and 實施獎勵根據Transplant(NHSBT)被管理，更多的亞洲和黑人的人們成為捐贈者的事的計劃的地區團體援助資金。

再加上主要企業的新的先進的產品和技術的可用性的強化的措施的高漲，對全球細胞凍結保存市場擴大也帶來著Plus的影響。2024年9月，Dover Corporation旗下的Colder Products Company(CPC)，在遺傳基因·細胞治療處理所使用的凍結盒式錄音帶髮表了持(有)直接適合的功能，新的無菌微連接器的銷售。凍結保存，治療對患者最小化做所提供前發生的保管中和產品出貨中的材料的功能降低有用。該公司的MicroCNX ULT連接器，管的殺菌連接效率性提供質樸的方法，與刺激強的化學品也對應著。被預測根據這樣的銷售，在生物安全櫃外邊的無菌連接變得可能，生物學的檢體的運輸變得容易。

本報告提供全球細胞凍結保存市場相關調查分析，市場規模與預測，市場動態，提供著主要企業的形勢等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 全球細胞凍結保存市場預測(2017年～2031年)

  • 市場規模的分析與預測
    • 金額
  • 市場佔有率的分析與預測
    • 各產品
    • 各用途
    • 各終端用戶
    • 各地區
    • 市場佔有率分析:各企業(金額)(前五名公司和其他 - 2023年)
  • 市場地圖分析(2023年)
    • 各產品
    • 各用途
    • 各終端用戶
    • 各地區

第5章 北美的細胞凍結保存市場預測(2017年～2031年)

  • 市場規模的分析與預測
    • 金額
  • 市場佔有率的分析與預測
    • 各產品
    • 各用途
    • 各終端用戶
    • 佔有率:各國
  • 各國的市場評估
    • 美國的細胞凍結保存市場預測(2017年～2031年)
    • 加拿大
    • 墨西哥

第6章 歐洲的細胞凍結保存市場預測(2017年～2031年)

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第7章 亞太地區的細胞凍結保存市場預測(2017年～2031年)

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第8章 南美的細胞凍結保存市場預測(2017年～2031年)

  • 巴西
  • 阿根廷

第9章 中東·非洲的細胞凍結保存市場預測(2017年～2031年)

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 以色列

第10章 供需分析

第11章 價值鏈分析

第12章 波特的五力分析

第13章 大環境分析

第14章 價格分析

第15章 市場動態

  • 推動市場要素
  • 市場課題

第16章 市場趨勢與發展

第17章 法規結構和革新

  • 臨床試驗
  • 法規當局的認證

第18章 專利形勢

第19章 案例研究

第20章 競爭情形

  • 市場領導者前五名公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 主要企業前十大企業的形勢
    • Merck & Co., Inc.
    • Thermo Fisher Scientific Inc.
    • Lonza Group Ltd.
    • GE HealthCare Technologies Inc.
    • BioLife Solutions Inc.
    • Sartorius AG
    • STEMCELL Technologies Canada Inc.
    • Artivion, Inc.
    • Takara Bio Inc.
    • Corning Incorporated

第21章 策略性推薦

第22章 本公司相關資料，免責聲明

Product Code: MX12252

Global cell cryopreservation market is projected to witness a CAGR of 21.58% during the forecast period 2024-2031, growing from USD 9.53 billion in 2023 to USD 45.49 billion in 2031. The market's growth is supported by the increasing utilization of cell therapies in various diseases, rising requirements for biobanks, increasing requirements from IVF clinics, growing efforts to preserve biological specimens for longer periods, and rising efforts of the key players of the market to introduce technologically advanced equipment.

Additionally, the rising efforts of different governments to promote stem cells, organs, and blood donations among different ethnicities are also boosting the growth of the cell cryopreservation market. In 2023, fifty organizations and community groups across Wales and England received a share from funding of approximately USD 890,000 (£685,000) as part of the government's efforts to tackle health inequalities among Asian and Black communities. Previously known as the Community Investment Scheme, the Community Grants Program is managed by the National Health Service Blood and Transplant (NHSBT) and aids in funding community organizations to deliver projects that encourage more Asian and Black individuals to become donors.

Furthermore, the rising efforts of leading companies to augment the availability of novel and advanced products and technologies are also positively influencing the expansion of the global cell cryopreservation market. In September 2024, Colder Products Company (CPC), a part of the Dover Corporation, announced the launch of a novel aseptic micro-connector that has the ability to fit directly into the freeze cassettes used in gene and cell therapy processing. Cryopreservation aids in minimizing material loss of function during storage and product shipment, which occurs prior to therapies being delivered to patients. The company's MicroCNX ULT connectors provide an efficient and simple method for the sterile connection of tubing and are also compatible with harsh chemicals. Such launches are expected to aid in creating sterile connections outside the biosafety cabinets, allowing for easy transport of biological specimens.

Increasing Construction of Biobanks Boosts Market Demand

The rapid expansion of disease prevention research and increasing requirement for targeted therapies and precision medicine are propelling the requirement for biobanks. Various governments also provide funding and donations to biobanks to support and promote research activities across various domains. In February 2024, the UK government provided an additional USD 27 million (£21 million) for the USD 97 million (£75 million) UK Biobank Limited in Manchester.

Additionally, various integrated healthcare providers are also investing in the construction of biobank facilities in different regions across the globe. In May 2024, CIC Innovation Services LLC and CHA Medical & Bio Group signed a memorandum of understanding for establishing an open innovation center focusing on innovation and research around the Cell Gene Biobank (CGB). Both companies agreed to collaborate to create a biotech-focused innovation ecosystem for supporting and attracting biotech companies and related ventures to CGB, which is being constructed by the CHA Medical & Bio Group in Pangyo, South Korea. Such activities are expected to boost the growth of the research sector and positively influence the expansion of the global cell cryopreservation market.

Technological Advancements Support Market Expansion

The growing efforts by various biotech companies to bolster the development and availability of novel cell cryopreservation technologies to increase convenience and redefine standards for cryopreservation are boosting the global cell cryopreservation market growth. In October 2024, Nucleus Biologics, LLC, one of the leading providers of bioprocessing and cell culture solutions for the gene and cell therapy sector, launched NB-KUL DF, a chemically defined, DMSO-free cryomedia set to redefine the standards of cryopreservation. NB-KUL DF outperforms other DMSO-free options in cell expansion, viability, and recovery. Additionally, NB-KUL DF eliminates the issues associated with DMSO-based media, such as the requirement for complex wash steps, patient issues, and additional variability and costs. Such launches mark a new era for cell cryopreservation for therapies and showcase the biotech companies' efforts to create products that make therapies more accessible and consistent for patients.

Additionally, various biotech companies are entering into collaborations and partnerships with others to accelerate the development of novel products and technologies. In October 2023, Cryoport, Inc. and NMDP BioTherapies (formerly known as Be The Match BioTherapies) announced a partnership to expand the former's capabilities and provide global cryopreservation and bioprocessing support across Europe and the United States.

IVF Clinics Hold Significant Market Share

The rising cases of infertility and the increasing requirement for the freezing and donating of biological material are propelling the segment's expansion and bolstering the global cell cryopreservation market size. As per the estimates of the World Health Organization (WHO), 1 in 6 adults across the globe experience infertility in their lifetime. Thus, propelling the requirement for effective and dependable cryopreservation solutions to ensure the viability of frozen eggs and sperm for long periods of time. Additionally, the rising cases of infertility are also augmenting the construction of fertility clinics in various regions across the globe, providing lucrative growth opportunities to the market. In June 2024, a new state-of-the-art fertility clinic was opened in Walnut Creek, United States, to address the rising requirement for expert fertility care. The increasing acceptance and awareness of assisted reproductive technologies (ART) is also boosting the demand for cell cryopreservation tools by IVF clinics. Various government and non-government organizations (NGOs) are also working on raising awareness about infertility, destigmatizing ARTs, and promoting education and understanding.

North America Holds Major Market Share

The expansion of the North American cell cryopreservation market is driven by the increasing emphasis on research and development activities, rising investments in the biotech sector, and the presence of advanced healthcare infrastructure. Additionally, the strong presence of leading market players in the region also provides lucrative growth opportunities for the market by ensuring the availability of advanced and novel technologies. The increased product demand can also be attributed to the rising construction of biobanks in countries such as the United States to support medical research for developing new and personalized therapies.

Furthermore, the rising efforts of various companies and research organizations to expedite cell and gene therapy development and manufacturing are also propelling the market's demand. In June 2023, GenScript Biotech Corporation and Comprehensive Cell Solutions, a business unit of New York Blood Center, Inc., announced their partnership to spearhead the development of gene and cell therapies to offer seamless and unique solutions that span apheresis and cell collections through cryopreservation of final therapeutics. The partnership will also focus on aiding drug developers in advancing treatment options for immune disorders and blood cancer. Additionally, the increasing breakthroughs in the region in gene and cell therapies are further augmenting the demand for reliable cryopreservation equipment to support clinical trials, distribution, and manufacturing activities.

Future Market Scenario (2024-2031F)

As per the global cell cryopreservation market analysis, the increasing investments in biobanking, advancements in cryoprotectant formulations, and automated cryopreservation systems are expected to provide lucrative growth opportunities to the market. Private organizations and governments across the globe are significantly investing in establishing biobanks to support drug discovery and disease research. Such initiatives are anticipated to boost the market's growth as biobanking facilities rely on effective cryopreservation technologies for storing biological specimens and ensuring they remain viable for future use. The growing popularity of personalized medicines is also expected to bolster the demand for efficient cell storage solutions, propelling the global cell cryopreservation market demand.

Moreover, the growing focus on cell-based therapies for treating autoimmune diseases, neurological disorders, and cancer, among others, is also expected to bolster the requirement for cell cryopreservation products. According to the estimates of the World Health Organization (WHO), over 35 million new cases of cancer are expected to occur in 2050. Additionally, the market is also expected to benefit from the increasing initiatives that aim to improve the regulatory framework, allowing companies to bring novel products to the market with ease.

Key Players Landscape and Outlook

The rising efforts by the key market players towards novel product launches are providing lucrative growth opportunities for the market. In June 2023, BioLife Solutions Inc, one of the leading suppliers and developers of class-defining bioproduction services and products for gene and cell therapy, announced the launch of their new, large-capacity controlled-rate freezer (CRF). The IntelliRate i67C tabletop freezer fulfills the growing customer requirement for high production of cell therapies. The new CRF has been designed to increase single-batch, LN2 CRF capacity from commercial manufacturing volumes to late- and mid-stage clinical research. Additionally, in October 2024, Cryoport, Inc. announced the launch of their IntegriCell cryopreservation solution provided by Cryoport Systems, along with the opening of their new facility in Texas, United States. The new facility is developed for standardized cryopreservation of leukapheresis material to support the commercialization and development of cell-based therapies. IntegriCell is designed to enhance cell therapy manufacturing efficiency and ensure quality, safety, and product stability to support the development of lifesaving treatment. Such developments and investments are expected to aid the key players in expanding their market share while positively influencing the expansion of the cell cryopreservation market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Cell Cryopreservation Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Cell Freezing Media
        • 4.2.1.1.1. Ethylene Glycol
        • 4.2.1.1.2. Dimethyl Sulfoxide
        • 4.2.1.1.3. Glycerol
        • 4.2.1.1.4. Others
      • 4.2.1.2. Equipment
        • 4.2.1.2.1. Freezers
        • 4.2.1.2.2. Incubators
        • 4.2.1.2.3. Liquid Nitrogen Supply Tanks
      • 4.2.1.3. Consumables
        • 4.2.1.3.1. Cryogenic Vials
        • 4.2.1.3.2. Cryogenic Tubes
        • 4.2.1.3.3. Cooler Boxes/Containers
        • 4.2.1.3.4. Others
    • 4.2.2. By Application
      • 4.2.2.1. Stem Cells
      • 4.2.2.2. Oocytes and Embryonic cells
      • 4.2.2.3. Sperm Cells
      • 4.2.2.4. Hepatocytes
      • 4.2.2.5. Others
    • 4.2.3. By End-user
      • 4.2.3.1. Biopharmaceutical and Pharmaceutical Companies
      • 4.2.3.2. Research Institutes
      • 4.2.3.3. Biobanks
      • 4.2.3.4. IVF Clinics
      • 4.2.3.5. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Application
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America Cell Cryopreservation Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Cell Freezing Media
        • 5.2.1.1.1. Ethylene Glycol
        • 5.2.1.1.2. Dimethyl Sulfoxide
        • 5.2.1.1.3. Glycerol
        • 5.2.1.1.4. Others
      • 5.2.1.2. Equipment
        • 5.2.1.2.1. Freezers
        • 5.2.1.2.2. Incubators
        • 5.2.1.2.3. Liquid Nitrogen Supply Tanks
      • 5.2.1.3. Consumables
        • 5.2.1.3.1. Cryogenic Vials
        • 5.2.1.3.2. Cryogenic Tubes
        • 5.2.1.3.3. Cooler Boxes/Containers
        • 5.2.1.3.4. Others
    • 5.2.2. By Application
      • 5.2.2.1. Stem Cells
      • 5.2.2.2. Oocytes and Embryonic cells
      • 5.2.2.3. Sperm Cells
      • 5.2.2.4. Hepatocytes
      • 5.2.2.5. Others
    • 5.2.3. By End-user
      • 5.2.3.1. Biopharmaceutical and Pharmaceutical Companies
      • 5.2.3.2. Research Institutes
      • 5.2.3.3. Biobanks
      • 5.2.3.4. IVF Clinics
      • 5.2.3.5. Others
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Cell Cryopreservation Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Cell Freezing Media
          • 5.3.1.2.1.1.1. Ethylene Glycol
          • 5.3.1.2.1.1.2. Dimethyl Sulfoxide
          • 5.3.1.2.1.1.3. Glycerol
          • 5.3.1.2.1.1.4. Others
          • 5.3.1.2.1.2. Equipment
          • 5.3.1.2.1.2.1. Freezers
          • 5.3.1.2.1.2.2. Incubators
          • 5.3.1.2.1.2.3. Liquid Nitrogen Supply Tanks
          • 5.3.1.2.1.3. Consumables
          • 5.3.1.2.1.3.1. Cryogenic Vials
          • 5.3.1.2.1.3.2. Cryogenic Tubes
          • 5.3.1.2.1.3.3. Cooler Boxes/Containers
          • 5.3.1.2.1.3.4. Others
        • 5.3.1.2.2. By Application
          • 5.3.1.2.2.1. Stem Cells
          • 5.3.1.2.2.2. Oocytes and Embryonic cells
          • 5.3.1.2.2.3. Sperm Cells
          • 5.3.1.2.2.4. Hepatocytes
          • 5.3.1.2.2.5. Others
        • 5.3.1.2.3. By End-user
          • 5.3.1.2.3.1. Biopharmaceutical and Pharmaceutical Companies
          • 5.3.1.2.3.2. Research Institutes
          • 5.3.1.2.3.3. Biobanks
          • 5.3.1.2.3.4. IVF Clinics
          • 5.3.1.2.3.5. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Cell Cryopreservation Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Cell Cryopreservation Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Cell Cryopreservation Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Cell Cryopreservation Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Clinical Trials
  • 17.2. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Merck & Co., Inc.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 20.3.2. Thermo Fisher Scientific Inc.
    • 20.3.3. Lonza Group Ltd.
    • 20.3.4. GE HealthCare Technologies Inc.
    • 20.3.5. BioLife Solutions Inc.
    • 20.3.6. Sartorius AG
    • 20.3.7. STEMCELL Technologies Canada Inc.
    • 20.3.8. Artivion, Inc.
    • 20.3.9. Takara Bio Inc.
    • 20.3.10. Corning Incorporated

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 3. Global Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 4. Global Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 5. Global Cell Cryopreservation Market Share (%), By Region, 2017-2031F
  • Figure 6. North America Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 7. North America Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 8. North America Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 9. North America Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 10. North America Cell Cryopreservation Market Share (%), By Country, 2017-2031F
  • Figure 11. United States Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 12. United States Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 13. United States Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 14. United States Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 15. Canada Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. Canada Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 17. Canada Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 18. Canada Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 19. Mexico Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 20. Mexico Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 21. Mexico Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 22. Mexico Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 23. Europe Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. Europe Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 25. Europe Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 26. Europe Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 27. Europe Cell Cryopreservation Market Share (%), By Country, 2017-2031F
  • Figure 28. Germany Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Germany Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 30. Germany Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 31. Germany Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 32. France Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 33. France Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 34. France Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 35. France Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 36. Italy Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 37. Italy Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 38. Italy Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 39. Italy Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 40. United Kingdom Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. United Kingdom Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 42. United Kingdom Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 43. United Kingdom Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 44. Russia Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 45. Russia Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 46. Russia Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 47. Russia Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 48. Netherlands Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 49. Netherlands Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 50. Netherlands Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 51. Netherlands Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 52. Spain Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Spain Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 54. Spain Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 55. Spain Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 56. Turkey Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 57. Turkey Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 58. Turkey Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 59. Turkey Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 60. Poland Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Poland Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 62. Poland Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 63. Poland Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 64. South America Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. South America Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 66. South America Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 67. South America Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 68. South America Cell Cryopreservation Market Share (%), By Country, 2017-2031F
  • Figure 69. Brazil Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Brazil Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 71. Brazil Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 72. Brazil Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 73. Argentina Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 74. Argentina Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 75. Argentina Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 76. Argentina Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 77. Asia-Pacific Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 78. Asia-Pacific Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 79. Asia-Pacific Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 80. Asia-Pacific Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 81. Asia-Pacific Cell Cryopreservation Market Share (%), By Country, 2017-2031F
  • Figure 82. India Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. India Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 84. India Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 85. India Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 86. China Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 87. China Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 88. China Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 89. China Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 90. Japan Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 91. Japan Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 92. Japan Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 93. Japan Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 94. Australia Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. Australia Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 96. Australia Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 97. Australia Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 98. Vietnam Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 99. Vietnam Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 100. Vietnam Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 101. Vietnam Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 102. South Korea Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. South Korea Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 104. South Korea Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 105. South Korea Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 106. Indonesia Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 107. Indonesia Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 108. Indonesia Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 109. Indonesia Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 110. Philippines Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 111. Philippines Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 112. Philippines Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 113. Philippines Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 114. Middle East & Africa Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 115. Middle East & Africa Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 116. Middle East & Africa Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 117. Middle East & Africa Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 118. Middle East & Africa Cell Cryopreservation Market Share (%), By Country, 2017-2031F
  • Figure 119. Saudi Arabia Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 120. Saudi Arabia Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 121. Saudi Arabia Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 122. Saudi Arabia Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 123. UAE Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 124. UAE Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 125. UAE Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 126. UAE Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 127. South Africa Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
  • Figure 128. South Africa Cell Cryopreservation Market Share (%), By Product, 2017-2031F
  • Figure 129. South Africa Cell Cryopreservation Market Share (%), By Application, 2017-2031F
  • Figure 130. South Africa Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
  • Figure 131. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023